Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (321-330 of 669) with videos related to

Pageof 67
Sort By:
Annals of Surgical Oncology|June 2, 2011
High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinomaYong Li, Zhe-Sheng Wen, Hao-Xian Yang, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) InhibitorZhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, et al.
Molecular Cancer|January 19, 2020
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancerLei Zhang, Yidong Li, Qianchao Wang, et al.
Molecular Cancer|March 14, 2020
Long non-coding RNAs regulate drug resistance in cancerKaisheng Liu, Lin Gao, Xiaoshi Ma, et al.
Journal of Natural Products|September 14, 2017
6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer AgentsShengtao Xu, Hong Yao, Mei Hu, et al.
ACS Applied Materials & Interfaces|September 2, 2016
Paper-Based Inkjet-Printed Flexible Electronic CircuitsYan Wang, Hong Guo, Jin-Ju Chen, et al.
International Journal of Molecular Medicine|October 24, 2025
Exportin 1 inhibitor KPT‑330 reverses oxaliplatin resistance via p53 nuclear retention in colorectal cancerChuanxi Lai, Xiya Jia, Yiyi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 13, 2025
Dual-Pedicle Tissue-Engineered Trachea Promotes Biomimetic Cartilaginous Framework, Vascularization, and Epithelial Lining for Long-Segment Tracheal ReconstructionZiming Wang, Yuming Wang, Zihao Chen, et al.
Cancer Letters|July 10, 2026
A Novel Immune Checkpoint-based Signature Predicts Immunotherapy Benefit in "Driver Gene-negative" Lung AdenocarcinomaBaohong Luo, Qinru Zhan, Yu Chen, et al.
Molecular Cancer|July 6, 2023
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancerFeng Ye, Saikat Dewanjee, Yuehua Li, et al.
Pageof 67

Showing results (321-330 of 669) with videos related to

Sort By:
Pageof 67
Annals of Surgical Oncology|June 2, 2011
High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinomaYong Li, Zhe-Sheng Wen, Hao-Xian Yang, et al.
Frontiers in Cell and Developmental Biology|August 2, 2021
Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) InhibitorZhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, et al.
Molecular Cancer|January 19, 2020
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancerLei Zhang, Yidong Li, Qianchao Wang, et al.
Molecular Cancer|March 14, 2020
Long non-coding RNAs regulate drug resistance in cancerKaisheng Liu, Lin Gao, Xiaoshi Ma, et al.
Journal of Natural Products|September 14, 2017
6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer AgentsShengtao Xu, Hong Yao, Mei Hu, et al.
ACS Applied Materials & Interfaces|September 2, 2016
Paper-Based Inkjet-Printed Flexible Electronic CircuitsYan Wang, Hong Guo, Jin-Ju Chen, et al.
International Journal of Molecular Medicine|October 24, 2025
Exportin 1 inhibitor KPT‑330 reverses oxaliplatin resistance via p53 nuclear retention in colorectal cancerChuanxi Lai, Xiya Jia, Yiyi Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 13, 2025
Dual-Pedicle Tissue-Engineered Trachea Promotes Biomimetic Cartilaginous Framework, Vascularization, and Epithelial Lining for Long-Segment Tracheal ReconstructionZiming Wang, Yuming Wang, Zihao Chen, et al.
Cancer Letters|July 10, 2026
A Novel Immune Checkpoint-based Signature Predicts Immunotherapy Benefit in "Driver Gene-negative" Lung AdenocarcinomaBaohong Luo, Qinru Zhan, Yu Chen, et al.
Molecular Cancer|July 6, 2023
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancerFeng Ye, Saikat Dewanjee, Yuehua Li, et al.
Pageof 67